## Mechanistic Overview
AQP4 Autoantibodies in NMOSD Cause Bystander Oligodendrocyte Injury via Metabolic Coupling Disruption starts from the claim that modulating AQP4; SLC16A1 (MCT1); SLC16A3 (MCT4) within the disease context of neurodegeneration can redirect a disease-relevant process. The original description reads: "## Mechanistic Overview AQP4 Autoantibodies in NMOSD Cause Bystander Oligodendrocyte Injury via Metabolic Coupling Disruption starts from the claim that modulating AQP4; SLC16A1
**Molecular Mechanism and Rationale**
The aquaporin-4 (AQP4) water channel represents a critical component of the brain's clearance infrastructure, functioning as the primary facilitator of bulk fluid flow in the glymphatic system. AQP4 is predominantly expressed in astrocytic endfeet that ensheath cerebral blood vessels, where it forms orthogonal arrays of particles (OAPs) that create highly efficient water-conducting domains. The molecular organization of AQP4 involves two main isoforms: the
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
AQP4 recurs across 2 selected hypotheses with aligned directionality in neuroinflammation, vascular barrier glymphatic.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary
3/11
dimensions won
AQP4 Autoantibodies in NMOSD Cause Bysta
9/11
dimensions won
Loss of AQP4 Polarization Impairs Glymph
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.54
0.70
Evidence
0.52
0.78
Novelty
0.62
0.65
Feasibility
0.55
0.72
Impact
0.58
0.80
Druggability
0.45
0.68
Safety
0.62
0.65
Competition
0.75
0.60
Data
0.58
0.72
Reproducible
0.55
0.55
KG Connect
0.50
0.12
Score Breakdown
Dimension
AQP4 Autoantibodies in NMOSD C
Loss of AQP4 Polarization Impa
Mechanistic
0.540
0.700
Evidence
0.520
0.780
Novelty
0.620
0.650
Feasibility
0.550
0.720
Impact
0.580
0.800
Druggability
0.450
0.680
Safety
0.620
0.650
Competition
0.750
0.600
Data
0.580
0.720
Reproducible
0.550
0.550
KG Connect
0.500
0.118
Evidence
AQP4 Autoantibodies in NMOSD Cause Bystander Oligodendrocyte
No evidence citations yet
Loss of AQP4 Polarization Impairs Glymphatic Perivascular In
No evidence citations yet
Debate Excerpts
AQP4 Autoantibodies in NMOSD Cause Bystander Oligo
4 rounds · quality: 0.76
Persona-Theorist
# Therapeutic/Mechanistic Hypotheses: AQP4 Dysfunction in CNS Disorders
---
## Hypothesis 1: Loss of AQP4 Polarization Impairs Glymphatic Perivascular Influx, Causing Metabolite Accumulation
**Mech...
Persona-Skeptic
# Critical Evaluation of AQP4 Dysfunction Hypotheses
## Hypothesis 1: Loss of AQP4 Polarization → Glymphatic Failure
### Weak Links
| Issue | Explanation |
|-------|-------------|
| Causation vs. co...
Persona-Domain Expert
# Feasibility Assessment: AQP4-Targeted Therapeutic Hypotheses in CNS Disorders
## Executive Summary
Based on the skeptic's revised confidence scores (0.44–0.68), this assessment focuses on the thre...
Loss of AQP4 Polarization Impairs Glymphatic Periv
4 rounds · quality: 0.76
Persona-Theorist
# Therapeutic/Mechanistic Hypotheses: AQP4 Dysfunction in CNS Disorders
---
## Hypothesis 1: Loss of AQP4 Polarization Impairs Glymphatic Perivascular Influx, Causing Metabolite Accumulation
**Mech...
Persona-Skeptic
# Critical Evaluation of AQP4 Dysfunction Hypotheses
## Hypothesis 1: Loss of AQP4 Polarization → Glymphatic Failure
### Weak Links
| Issue | Explanation |
|-------|-------------|
| Causation vs. co...
Persona-Domain Expert
# Feasibility Assessment: AQP4-Targeted Therapeutic Hypotheses in CNS Disorders
## Executive Summary
Based on the skeptic's revised confidence scores (0.44–0.68), this assessment focuses on the thre...